Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation

Corporate Takeovers and Economic Efficiency

In the paper, Corporate Takeovers and Economic Efficiency, written for the Annual Review of Financial Economics, I review recent takeover research which advances our understanding of the role of M&A in the drive for productive efficiency. Much of this research places takeovers in the context of industrial organization, tracing with unprecedented level of detail “who […]

Click here to read the complete post
Posted in Academic Research, Mergers & Acquisitions | Tagged , , , , | Comments Off on Corporate Takeovers and Economic Efficiency

An Upturn in “Inversion” Transactions

Recently, there have been a growing number of large “inversion” transactions involving the migration of a U.S. corporation to a foreign jurisdiction through an M&A transaction. Inversion transactions come in several varieties, with the most common involving a U.S. company merging with a foreign target and redomiciling the combined company to the jurisdiction of the […]

Click here to read the complete post
Posted in International Corporate Governance & Regulation, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , | Comments Off on An Upturn in “Inversion” Transactions

2014 Proxy Season: Early Indications

It is still early days, but here is what we are seeing as the 2014 proxy season unfolds: Institutional investors promote governance reforms and engagement efforts. Prior to the season Vanguard sent letters to S&P 500 companies seeking adoption of annual director elections, majority voting and the right of holders of 25% of the common […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Institutional Investors, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , , | 1 Comment

Public Compensation for Private Harm: SEC’s Fair Fund Distribution

The SEC’s success is conventionally measured by the number of enforcement actions it brings, the multimillion-dollar fines it secures, and the high-impact trials it wins. But the SEC does more than punish wrongdoing. Over the last twelve years, the SEC has quietly become an important source of compensation for defrauded investors. Since 2002, the SEC […]

Click here to read the complete post
Posted in Academic Research, Empirical Research, Securities Litigation & Enforcement | Tagged , , , , , , , | Comments Off on Public Compensation for Private Harm: SEC’s Fair Fund Distribution

Inversions—Upside for Acquisitions

With U.S. corporate tax rates among the highest in the world, U.S.-based companies with international operations regularly look for structuring opportunities to reduce the exposure of their overseas earnings to U.S. taxes. A recent trend driving deal activity is the prevalence of acquisition-related inversions whereby the acquiring company redomiciles to a lower-tax jurisdiction concurrently with […]

Click here to read the complete post
Posted in International Corporate Governance & Regulation, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , | 1 Comment

Span of Control and Span of Attention

In our paper, Span of Control and Span of Attention, which was recently made publicly available on SSRN, we use novel data to better understand the role of the CEO and the relationship to the executive team as represented by the CEO’s span of control. We collect detailed time use information for a large sample […]

Click here to read the complete post
Posted in Academic Research | Tagged , , | Comments Off on Span of Control and Span of Attention

Schedule 13D Ten-Day Window and Other Issues: Will the Pershing Square/Valeant Accumulation of a 9.7% Stake in Allergan Lead to Regulatory Action?

As widely reported, a vehicle formed by Pershing Square and Valeant Pharmaceuticals acquired just under 5% of Allergan’s shares after Allergan apparently rebuffed confidential efforts by Valeant to get Allergan to negotiate a potential acquisition. The Pershing Square/Valeant vehicle then crossed the 5% threshold and nearly doubled its stake (to 9.7%) over the next ten […]

Click here to read the complete post
Posted in Accounting & Disclosure, Mergers & Acquisitions, Practitioner Publications, Private Equity | Tagged , , , , , , , , , | Comments Off on Schedule 13D Ten-Day Window and Other Issues: Will the Pershing Square/Valeant Accumulation of a 9.7% Stake in Allergan Lead to Regulatory Action?

US G-SIB Leverage Surcharge and Basel III Leverage Ratio

The U.S. banking agencies have finalized higher leverage capital standards for the eight U.S. bank holding companies that have been identified as global systemically important banks (“U.S. G-SIBs”) and their insured depository institution (“IDI”) subsidiaries. The agencies also proposed important changes to the denominator of the U.S. Basel III supplementary leverage ratio (“SLR”). A number […]

Click here to read the complete post
Posted in Banking & Financial Institutions, Financial Regulation, International Corporate Governance & Regulation, Practitioner Publications | Tagged , , , , , , , , , , | Comments Off on US G-SIB Leverage Surcharge and Basel III Leverage Ratio

Council of Institutional Investors Presses SEC for Guidance on Interim Vote Tallies

Last May, Broadridge Financial Solutions, Inc., the provider of proxy services for over 90% of public companies and mutual funds in North America (“Broadridge”), decided to end its established practice of providing interim vote tallies (sometimes referred to as “preliminary voting results”) to proponents of shareholder proposals. Following this change in practice, the Council of […]

Click here to read the complete post
Posted in Accounting & Disclosure, Corporate Elections & Voting, Institutional Investors, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , | Comments Off on Council of Institutional Investors Presses SEC for Guidance on Interim Vote Tallies

A New Takeover Threat: Symbiotic Activism

The Pershing Square-Valeant hostile bid for Allergan has captured the imagination. Other companies are wondering whether they too will wake up one morning to find a raider-activist tag-team wielding a stealth block of their stock. Serial acquirers are asking whether they should be looking to take advantage of this new maneuver. Speculation and rumor abound […]

Click here to read the complete post
Posted in Mergers & Acquisitions, Practitioner Publications, Securities Regulation | Tagged , , , , , | Comments Off on A New Takeover Threat: Symbiotic Activism